FTO and acute myeloid leukemia: In turn, FTO upregulation enhances the expression of ASB2 and RARA by reducing m6A levels at untranslated regions (UTRs), thus inhibiting all-trans-retinoic acid (ATRA)-induced AML cell differentiation and promoting leukemogenesis (Figure 1).